1-20 of 25
Yafei Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

QLS4131, a next-generation GPRC5D×BCMA×CD3 trispecific T-cell engager, in patients with relapsed/refractory multiple myeloma (RRMM): Initial results of a first-in-human Phase Ⅰa study

Free
Gang An, Yafei Wang, Hui Guo, Wanhong Zhao, Xiaobing Huang, Zhongjun Xia, Jian Chen, Xianlin Duan, Zeyu Yang, Xiaoyan Kang, Lugui Qiu
Journal: Blood
Blood (2025) 146 (Supplement 1): 5831.
https://doi.org/10.1182/blood-2025-5831
Published: 2025
Journal Articles

A phase I monotherapy study assessing the safety and efficacy of GR1803, a BCMA×CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma

Free
Min Yang, Yang Liang, Guorong Wang, Baijun Fang, Luqun Wang, Songfu Jiang, Yafei Wang, Heng Mei, Wei Yang, Yanjuan He, Wei Wang, Haichao Zhang, Houguo Wang, Jie Jin, Wenming Chen
Journal: Blood
Blood (2025) 146 (Supplement 1): 5822.
https://doi.org/10.1182/blood-2025-5822
Published: 2025
Journal Articles

Isatuximab (Isa) subcutaneous (SC) via an on-body injector (OBI) vs isa intravenous (IV), plus pomalidomide and dexamethasone (Pd) in relapsed/refractory multiple myeloma (RRMM): East asia subgroup results from the randomized, non-inferiority, phase 3 iraklia study

Free
Xuelin Dou, Chunrui Li, Aijun Liao, Yafei Wang, Zhongjun Xia, Jing Liu, Hong Cen, Yan Xu, Fei Li, Tadao Ishida, Yuping Zhong, Satoshi Ito, Togano Tomiteru, Baijun Fang, Chunyan Sun, Hongmei Jing, Masaki Ri, Toshiyuki Kitano, Kazutaka Sunami, Chihiro Shimazaki, Shigeki Ito, Jie Jin, Rong Fu, Takuya Komeno, Kosei Matsue, Shang-Yi Huang, Sikander Ailawadhi, Florence Suzan Teisserenc, Dan Gao, Xu Wang, Yi Li, Gang Liu, Jin Lu
Journal: Blood
Blood (2025) 146 (Supplement 1): 5819.
https://doi.org/10.1182/blood-2025-5819
Published: 2025
Journal Articles

Dynamic monitoring of circulating plasma cells in multiple myeloma: A Prospective multicenter study in China

Free
Qun Li, Xiaojing Yan, Jian-Qing Mi, Aijun Liao, Bingzong Li, Hui-Han Wang, Huili Cai, Yafei Wang, Li Cai, Yu Hu, Chunyan Sun
Journal: Blood
Blood (2025) 146 (Supplement 1): 3984.
https://doi.org/10.1182/blood-2025-3984
Published: 2025
Journal Articles

Health-related quality of life in Chinese multiple myeloma patients treated with daratumumab-based regimens in real world: Exploratory analysis of the MMY4032

Free
Luqun Wang, Wei Yang, Yafei Wang, Ting Niu, Rong Fu, Yuping Zhong, Wenbin Qian, Kaiyang Ding, Kai Sun, Hong Liu, Baijun Fang, Hui Liu, Yanhui Li, Yishen Yang, Jianmin Zhuo, Xi Chen, Jin Lu
Journal: Blood
Blood (2025) 146 (Supplement 1): 7529.
https://doi.org/10.1182/blood-2025-7529
Published: 2025
Journal Articles

Weekly Selinexor, Bortizomib and Dexamethasone (SVd) Versus Twice Weekly Bortizomib and Dexamethasone (Vd) in Chinese Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Primary Analysis of Phase 3 Bench Study

Free
Jin Lu, Liangquan Geng, Lijuan Chen, Peng Liu, Yuping Zhong, Zhuogang Liu, Zhongjun Xia, Jianqing Mi, Chunrui Li, Xi Zhang, Yanjuan He, Yongqiang Wei, Baijun Fang, Fei Li, Zhen Cai, Yafei Wang, Dongping Huang, Hong Liu, Ming Hou, Rong Fu, Xin Du, Xiaosheng Fang, Qingshu Zeng, Wen Gao, Wei Wang, Chunkang Chang, Guifang Ouyang, Jing Liu, Jianyu Weng, Xiaobing Huang, Yang Yu, Zhi Guo, Jun Zhao, Jian Hou
Journal: Blood
Blood (2024) 144 (Supplement 1): 4748.
https://doi.org/10.1182/blood-2024-202893
Published: 2024
Journal Articles

Neuronal-Glial and Immune Microenvironment Signatures Show Prognostic Effects in Primary CNS Lymphoma

Free
Zijun Y. Xu-Monette, Xiaoxiao Wang, Govind Bhagat, Alexandar Tzankov, Qingyan Au, Carlo Visco, Harry Nunns, Alessandro La Ferlita, Lalit Sehgal, April Chiu, Heounjeong Go, Anamarija M. Perry, Huilan Rao, Mina Xu, Qiongli Zhai, Yafei Wang, Shi Wang, Wenbin Qian, Maurilio Ponzoni, Wen Shuai, Bangchen Wang, Sergio Pina-Oviedo, Luis Carrillo, Kelly Au, Santiago Montes-Moreno, Sr., Karen Dybkaer, Zenggang Pan, William Choi, Michael Møller, Luigi Racioppi, Xiaohui Zhang, Jinming Song, Shanxiang Zhang, Youli Zu, Joo Y. Song, Eric D. Hsi, Fenghuang Zhan, Benjamin M. Parsons, Aliyah R. Sohani, Weina Chen, Fabio Iwamoto, Jeremy S. Abramson, Bing Xu, Yong Li, Ken H. Young
Journal: Blood
Blood (2024) 144 (Supplement 1): 4361.
https://doi.org/10.1182/blood-2024-201598
Published: 2024
Journal Articles

Efficacy and Safety Results of TQB3909 in Patients (Pts) with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Free
Keshu Zhou, Hongyun Xing, Qingliang Teng, Wuping Li, Yafei Wang, Feng Zhu, Zhengming Jin, Li Zhiming, Guifang Ouyang, Fang Xu, Shihua Huang, Jianyong Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 4627.
https://doi.org/10.1182/blood-2024-202814
Published: 2024
Journal Articles

Real-World Clinical Outcomes of Daratumumab-Based Regimens in Chinese Patients with Multiple Myeloma By Cytogenetic Risk: A Subgroup Analysis of the MMY4032 Study

Free
Luqun Wang, Wei Yang, Ting Niu, Yafei Wang, Rong Fu, Yuping Zhong, Kaiyang Ding, Kai Sun, Baijun Fang, Hong Liu, Wenbin Qian, Hui Liu, Yanhui Li, Yishen Yang, Jianmin Zhuo, Xi Chen, Canchan Cui, Jin Lu
Journal: Blood
Blood (2024) 144 (Supplement 1): 7874.
https://doi.org/10.1182/blood-2024-201134
Published: 2024
Journal Articles

Daratumumab, Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) Alone in Transplant-Ineligible Asian Patients with Newly Diagnosed Multiple Myeloma: Final Analysis of the Phase 3 Octans Study

Free
Weijun Fu, Soo-Mee Bang, Honghui Huang, Kihyun Kim, Wei Li, Gang An, Je-Jung Lee, Zhen Cai, Jie Jin, Yafei Wang, Chor Sang Chim, Robin Carson, Rui Liu, Lingling Wang, Man Zhao, Xi Chen, Canchan Cui, Jian Hou, Jianxiang Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 3388.
https://doi.org/10.1182/blood-2023-181063
Published: 2023
Journal Articles

Real-World Analysis of Treatment Patterns and the Effectiveness and Safety Profile of Daratumumab-Based Regimens in Chinese Patients with Newly Diagnosed or Relapsed/Refractory Multiple Myeloma

Free
Luqun Wang, Wei Yang, Yafei Wang, Ting Niu, Rong Fu, Yuping Zhong, Wenbin Qian, Kaiyang Ding, Kai Sun, Hong Liu, Baijun Fang, Hui Liu, Yanhui Li, Yishen Yang, Jianmin Zhuo, Xi Chen, Canchan Cui, Jin Lu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6635.
https://doi.org/10.1182/blood-2023-180948
Published: 2023
Journal Articles

Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study

Free
Huixing Zhou, Long Chang, Jing Jia, Jie Ma, Hua Xue, Hao Li, Wenrong Huang, Hebing Zhou, Jingnan Sun, Liping Su, Yanping Ma, Huang Hongming, Hongmei Jing, Zhenling Li, Guangyu Ma, Guohong Su, Jihao Zhou, Biyun Chen, LI Bao, Zhihua Zhang, Lin Yang, Haiping Yang, Yanhong Zhao, Chunyan Sun, Qingming Wang, Qimuge Saiyin, Da Gao, Xiaoxia Chu, Zhenfang Xi, Weiwei Tian, Xuliang Shen, Shi Minxia, Jin Zhang, Yi Chen, Jingbo Xu, Yao Liu, Hongling Peng, Weijun Fu, Jun Luo, Zhenyu Li, Hui-Han Wang, Xiaobo Wang, Xiuli Sun, Jinqiao Zhang, Wei WANG, Yan Yan, Yafei Wang, Xin Du, Yonghuai Feng, Yi Wang, Ying Sun, Liye Zhong, Li Gao, Wenming Chen, Jian Li, Wen Gao
Journal: Blood
Blood (2023) 142 (Supplement 1): 4754.
https://doi.org/10.1182/blood-2023-180736
Published: 2023
Journal Articles

Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Higher Risk Myelodysplastic Syndromes (MDS)

Free
Wei Yang, Sujun Gao, Xiaojing Yan, Rong Guo, Lijie Han, Fei Li, Yafei Wang, Junmin Li, Chunkang Chang, Haiping Yang, Ronghua Hu, Hongyan Tong, Xingli Zhao, Qiubai Li, Jingdong Zhang, Xin Du, Sanfang Tu, Cheng Zhang, Congmeng Lin, Xin Du, Zhenling Li, Ligen Liu, Zhenyu Li, Zheng Dong, Yixuan Yang, Qiying Lu, Wenzhi Tian, Zhijian Xiao
Journal: Blood
Blood (2023) 142 (Supplement 1): 320.
https://doi.org/10.1182/blood-2023-174420
Published: 2023
Journal Articles

Subgroup Analyses of Progression-Free Survival from the Phase 3 Octans and Alcyone Studies in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Bortezomib, Melphalan, and Prednisone with or without Daratumumab

Free
Weijun Fu, Soo-Mee Bang, Honghui Huang, Kihyun Kim, Wei Li, Gang An, Je-Jung Lee, Zhen Cai, Jie Jin, Yafei Wang, Chor Sang Chim, Paula Rodriguez Otero, Meletios A. Dimopoulos, Tomoaki Fujisaki, Jae Hoon Lee, Susan Wroblewski, Fredrik Borgsten, Robin Carson, Rui Liu, Man Zhao, Tingting Wu, Xi Chen, Canchan Cui, Jian Hou, Jianxiang Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 2006.
https://doi.org/10.1182/blood-2023-180809
Published: 2023
Journal Articles

Daratumumab, Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma: Pooled Analysis of Octans and Alcyone

Free
Jian Hou, Weijun Fu, Soo-Mee Bang, Honghui Huang, Kihyun Kim, Wei Li, Gang An, Je-Jung Lee, Zhen Cai, Jie Jin, Yafei Wang, CS Chim, Paula Rodriguez-Otero, Meletios A. Dimopoulos, Tomoaki Fujisaki, Jae Hoon Lee, Susan Wroblewski, Robin Carson, Ming Qi, Jianping Wang, Yang Song, Bin Jia, Xue Yang, Wenyu Liu, Yunan Li, Renyi Zhang, Jianxiang Wang
Journal: Blood
Blood (2021) 138 (Supplement 1): 1661.
https://doi.org/10.1182/blood-2021-146974
Published: 2021
Journal Articles

Progression-Free Survival Outcomes By Response Status for Bortezomib, Melphalan, and Prednisone with or without Daratumumab in Newly Diagnosed Multiple Myeloma: Pooled Subgroup Analysis of Octans and Alcyone

Free
Jianxiang Wang, Weijun Fu, Soo-Mee Bang, Honghui Huang, Kihyun Kim, Wei Li, Gang An, Je-Jung Lee, Zhen Cai, Jie Jin, Yafei Wang, CS Chim, Paula Rodriguez-Otero, Anna Marina Liberati, Hiroyuki Takamatsu, Jae Hoon Lee, Meletios A. Dimopoulos, Susan Wroblewski, Robin Carson, Ming Qi, Jianping Wang, Yang Song, Bin Jia, Xue Yang, Wenyu Liu, Yunan Li, Renyi Zhang, Jian Hou
Journal: Blood
Blood (2021) 138 (Supplement 1): 1648.
https://doi.org/10.1182/blood-2021-148937
Published: 2021
Journal Articles

Trial in Progress: A Perspective Study of Pan-Oral Triplet Regimen Pomalidomide, Ixazomib and Dexamethasone in Relapsed or Refractory Myeloma Patients

Free
Miao Chen, Li Bao, Wenming Chen, Rong Fu, Rong Guo, Hongmei Jing, Hui Liu, Qinhua Liu, Yanping Ma, Xiuli SUN, Wei Wang, Yafei Wang, Xiaojing Yan, Jiang Qian, Junling Zhuang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4783.
https://doi.org/10.1182/blood-2021-148237
Published: 2021
Journal Articles

Daratumumab, Bortezomib, Dexamethasone (D-Vd) Versus Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory (RR) Multiple Myeloma (MM): Pooled Subgroup Analysis of Lepus and Castor

Free
Jin Lu, Weijun Fu, MDPhD, Wei Li, MD, Jianda Hu, MDPhD, Gang An, MD PhD, Yafei Wang, Chengcheng Fu, Lijuan Chen, MDPhD, Jie Jin, MD PhD, Xinan Cen, Zheng Ge, MDPhD, Zhen Cai, MD PhD, Ting Niu, MD PhD, Andrew Spencer, DM, Katja Weisel, MD, María-Victoria Mateos, MD PhD, Ajay Nooka, MDMPH, Ming Qi, MD PhD, Steven Sun, Xue Gai, Weiping Liu, Xue Yang, Xiaojun Huang
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–41.
https://doi.org/10.1182/blood-2020-136108
Published: 2020
Journal Articles

Modified Conditioning Regimen with Idarubicin Prior to Autologous Hematopoietic Stem Cell Transplantation in B-Cell Non-Hodgkin Lymphoma

Free
Chen Tian, MD PhD, Yueyang Li, M. James You, MD PhD, Zhigang Zhao, Yizhuo Zhang, MD, Yafei WANG
Journal: Blood
Blood (2019) 134 (Supplement_1): 5349.
https://doi.org/10.1182/blood-2019-122089
Published: 2019
Journal Articles

Management of Primary Gastrointestinal Non-Hodgkin Lymphoma with Lenalidomide

Free
Chen Tian, MD PhD, Yueyang Li, Yafei Wang, M. James You, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5354.
https://doi.org/10.1182/blood-2019-122159
Published: 2019